Preclin Biosystems


	Models Infectious disease Autoimmune diseases Lung diseases Intestinal diseases Preclin Biosystems’ approach

Preclin Biosystems AG Preclin Biosystems AG offers a comprehensive in vivo preclinical testing platform for the identification and validation of lead candidate therapeutics.
	Our extensive range of chronic inflammatory and infectious disease models are run routinely in our core facility providing a ‘one stop shop’ for preclinical drug efficacy testing. Our parallel testing approach for in vivo assessment of lead candidates can provide an overall efficacy, side effect and target market analysis condensing the preclinical phase of drug development dramatically. For more information on our service and partnership opportunities contact: info@preclinbiosystems.com

News

November 2010: Meet Preclin Biosystems AG at the Bio-Europe 2010 in Munich (15-17 November). To schedule a meeting contact:
info@preclinbiosystems.com

October 2010: Meet Preclin Biosystems AG at the BioAlps Business China 2010 in Shanghai and Beijing (October 10-16). To schedule a meeting contact:
info@preclinbiosystems.com

September 2010: Meet Preclin Biosystems AG at the Biobusiness Network in Geneva (29-30 September). To schedule a meeting contact:
info@preclinbiosystems.com

September 2010: Meet Preclin Biosystems AG at the BioPharm America 2010 in Boston (15-17 September). To schedule a meeting contact:
info@preclinbiosystems.com

info@preclinbiosystems.com